知镜 Cognispect · 医学文献与研究工作台

Pediatric inflammatory bowel disease in New Zealand study: a 10-year update on national incidence and point prevalence in 2025.

Cherry CTL, Evans HM, Mouat SW, Bishop JR, Roberts AJ, Fireman N, Bhana A, Haszard JJ, Day AS, Lopez RN.
Crohn's & colitis 360 · 2026-10-28 · PMID 42979197

文献摘要

Background and aims The incidence of inflammatory bowel disease (IBD) in children is increasing worldwide, with high rates previously noted in New Zealand. The incidence and prevalence of pediatric IBD in New Zealand was last delineated in 2015. The aim of this study was to provide updated epidemiological data by delineating the incidence and prevalence of pediatric IBD in New Zealand ten years after the previous assessment. Methods For the incidence cohort, patients younger than 16 years with IBD, diagnosed between January 1, 2025 and December 31, 2025 were identified and information entered into a secure database. Population data were obtained and incidence calculated. To derive the point prevalence, all patients diagnosed with IBD under the age of 16 years on June 30, 2025 were identified and information entered into a secure database. Population data were obtained and prevalence calculated. Results The incidence of pediatric IBD, Crohn's disease (CD), ulcerative colitis (UC) and inflammatory bowel disease-unclassified (IBD-U) in New Zealand in 2025 was 8.0, 5.6, 2.0, and 0.4 per 100 000 respectively. The point prevalence of IBD, CD, UC, and IBD-U in children in New Zealand on June 30, 2025 was 33.0, 21.7, 8.1, and 3.2 per 100 000 respectively. Conclusions The incidence and prevalence of IBD have increased 1.5 times in children in New Zealand since 2015. New Zealand continues to have some of the highest rates of pediatric IBD in the world. Ongoing research is needed to understand factors leading to increasing rates and to ensure appropriate health service provision.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。